Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 247

1.

Anticoagulation in the elderly.

Dhond AJ, Michelena HI, Ezekowitz MD.

Am J Geriatr Cardiol. 2003 Jul-Aug;12(4):243-50. Review.

PMID:
12888705
2.

Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls.

Garwood CL, Corbett TL.

Ann Pharmacother. 2008 Apr;42(4):523-32. doi: 10.1345/aph.1K498. Review.

PMID:
18334606
3.

Stroke prevention in elderly patients with atrial fibrillation.

Lew SJ, Lim JK.

Singapore Med J. 2002 Apr;43(4):198-201.

PMID:
12188065
4.

A review of anticoagulation with warfarin in patients with nonvalvular atrial fibrillation.

Abdelhafiz AH.

Clin Ther. 2001 Oct;23(10):1628-36. Review.

PMID:
11727726
5.

Atrial fibrillation and anticoagulation.

Maxim R.

Med Health R I. 2001 Mar;84(3):96-7. No abstract available.

PMID:
11280139
6.

Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.

Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.

Am J Geriatr Pharmacother. 2009 Jun;7(3):159-66. doi: 10.1016/j.amjopharm.2009.06.002.

PMID:
19616184
7.

Approach to management of the patient over age 75 with atrial fibrillation.

Michelena HI, Ezekowitz MD.

Cardiol Rev. 2000 Jan-Feb;8(1):9-16. Review.

PMID:
11174869
8.

Antithrombotic treatment in atrial fibrillation.

Lip GY, Boos CJ.

Postgrad Med J. 2008 May;84(991):252-8. doi: 10.1136/hrt.2005.066944. Review.

PMID:
18508982
9.

Stroke prevention in patients with atrial fibrillation.

Ono A, Fujita T.

J Clin Neurosci. 2003 Jan;10(1):71-3.

PMID:
12464526
10.

Stroke prevention in atrial fibrillation--pharmacologic strategies.

Tiyyagura SR, Goldbarg SH, Mehta D.

Indian Heart J. 2007 Jul-Aug;59(4):311-5. Review.

PMID:
19126935
11.

Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.

Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL; SPORTIF Investigators..

Am Heart J. 2006 Nov;152(5):967-73.

PMID:
17070169
12.

Antithrombotic management of atrial fibrillation for stroke prevention in older people.

Tong DC, Albers GW.

Clin Geriatr Med. 1999 Nov;15(4):645-62. Review.

PMID:
10499928
13.

Additional risk factors in atrial fibrillation patients not receiving warfarin.

Wensley S, Keir S, Caine S, Mac Mahon M.

Age Ageing. 1999 Jul;28(4):355-7.

PMID:
10459787
14.
15.
16.

Stroke: Atrial fibrillation, stroke prevention therapy and aging.

Spence JD.

Nat Rev Cardiol. 2009 Jul;6(7):448-50. doi: 10.1038/nrcardio.2009.98.

PMID:
19554003
17.

Anticoagulation for atrial fibrillation in the elderly.

Halperin JL.

Am J Geriatr Cardiol. 2005 Mar-Apr;14(2):81-6. Review.

PMID:
15785149
18.

Current status of anticoagulation therapy for elderly atrial fibrillation patients in Japan: from Hokuriku atrial fibrillation trial.

Furusho H, Takamura M, Takata S, Sakagami S, Hirazawa M, Kato T, Murai H, Okajima M, Kaneko S.

Circ J. 2008 Dec;72(12):2058-61.

19.

Atrial fibrillation and anticoagulation.

Garnier LF, Rouesnel P, Espitalier F.

Arch Mal Coeur Vaiss. 2004 Oct;97(10):1001-5. Review.

PMID:
16008178
20.

Preference-based antithrombotic therapy in atrial fibrillation: implications for clinical decision making.

Man-Son-Hing M, Gage BF, Montgomery AA, Howitt A, Thomson R, Devereaux PJ, Protheroe J, Fahey T, Armstrong D, Laupacis A.

Med Decis Making. 2005 Sep-Oct;25(5):548-59.

PMID:
16160210
Items per page

Supplemental Content

Support Center